Felix Sahm

German Cancer Research Center — Germany

Medicine · Health Sciences

91h-index39.5kcitations1.0kworks4.92yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Glioma Diagnosis and Treatment(618), Meningioma and schwannoma management(189), Brain Metastases and Treatment(83), Radiomics and Machine Learning in Medical Imaging(77), Neurofibromatosis and Schwannoma Cases(71)

Publications1.0k total

Intraoperative classification of glioblastoma through near real-time stimulated Raman scattering microscopy
2025Open Access
Loss of global DNA hypermethylation is prognostic in IDH-mutant and 1p/19q-codeleted oligodendrogliomas
Acta Neuropathologica·2025· 1 citedOpen Access
Supplementary Figure S3 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
2025Open Access
Supplementary Figure S5 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
2025Open Access
Supplementary Figure S2 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
2025Open Access
Supplementary Figure S6 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
2025Open Access
Supplementary Table S1 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
2025Open Access
Supplementary Figure S7 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
2025Open Access
Supplementary Figure S1 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
2025Open Access
Supplementary Figure S4 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
2025Open Access
Supplementary Table S2 from Prognostic Markers of DNA Methylation and Next-Generation Sequencing in Progressive Glioblastoma from the EORTC-26101 Trial
2025Open Access
Table S3 from T-cell Receptor Therapy Targeting Mutant Capicua Transcriptional Repressor in Experimental Gliomas
2025Open Access
Figure S2 from T-cell Receptor Therapy Targeting Mutant Capicua Transcriptional Repressor in Experimental Gliomas
2025Open Access
Table S2 from T-cell Receptor Therapy Targeting Mutant Capicua Transcriptional Repressor in Experimental Gliomas
2025Open Access
Table S1 from T-cell Receptor Therapy Targeting Mutant Capicua Transcriptional Repressor in Experimental Gliomas
2025Open Access
Figure S3 from T-cell Receptor Therapy Targeting Mutant Capicua Transcriptional Repressor in Experimental Gliomas
2025Open Access
Figure S1 from T-cell Receptor Therapy Targeting Mutant Capicua Transcriptional Repressor in Experimental Gliomas
2025Open Access
A Clinical Tool to Identify Incidental Meningioma for Early Outpatient Management
JAMA Oncology·2025Open Access
Analysis of anatomical location, mitoses, and Ki-67 in 2608 meningiomas
Journal of Neuropathology & Experimental Neurology·2025
A framework for using DNA methylation-based modelling for the clinical management of cranial meningioma
Neuro-Oncology·2025Open Access
page 1 of 51Next →

Frequent Co-authors

Andreas von Deimling(39), Wolfgang Wick(31), David Capper(23), Michael Platten(22), Christel Herold‐Mende(22), David Reuß(20), David Jones(18), Daniel Schrimpf(17), Christian Koelsche(17), Stefan M. Pfister(17), Michael Weller(16), Christian Mawrin(15), Jens Schittenhelm(14), Andreas Unterberg(12), Werner Paulus(11), Andrey Korshunov(11), Volker Hovestadt(10), Matthias Preusser(10), Daniel Hänggi(9), Benedikt Wiestler(9)